Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis.
Ioannou A, Fumagalli C, Razvi Y, Porcari A, Rauf MU, Martinez-Naharro A, Venneri L, Moody W, Steeds RP, Petrie A, Whelan C, Wechalekar A, Lachmann H, Hawkins PN, Solomon SD, Gillmore JD, Fontana M.
J Am Coll Cardiol. 2024 Jul 2;84(1):43-58. doi: 10.1016/j.jacc.2024.04.011. Epub 2024 May 13.
PMID:38739065
Aerobic Exercise Prescription: The Talk Test Rises Over the 6-Minute Walk Test.
Menezes MG, Fronza VA, Franzoni L.
Arq Bras Cardiol. 2023 Oct;120(9):e20230636. doi: 10.36660/abc.20230636.
PMID:37909576
Determinants of 6-minute walk test in people with Parkinson's disease.
Üğüt BO, Kalkan AC, Kahraman T, Dönmez Çolakoğlu B, Çakmur R, Genç A.
Ir J Med Sci. 2023 Feb;192(1):359-367. doi: 10.1007/s11845-022-02954-7. Epub 2022 Feb 24.
PMID:35199303
Prognostic value of Borg scale following 6-min walk test in hospitalized older patients with heart failure.
Saito H, Maeda D, Kagiyama N, Sunayama T, Dotare T, Fujimoto Y, Nakade T, Jujo K, Saito K, Kamiya K, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Wada H, Kasai T, Nagamatsu H, Momomura SI, Matsue Y.
Eur J Prev Cardiol. 2024 Dec 4;31(17):2036-2043. doi: 10.1093/eurjpc/zwae291.
PMID:39233355
[Within-subject variability of the 6-minute walk test].
Santos-Martínez LE, Flores-Morales MYD, Ordoñez-Reyna A, Arroyo-González JJ, Quevedo-Paredes J.
Rev Med Inst Mex Seguro Soc. 2022 Feb 1;60(1):26-32.